GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Medtronic, Inc. (MDT) [hlAlert]

Rating:
Overweight
MDT
up 15.28 %

Medtronic, Inc. (MDT) rated Overweight with price target $73 by Barclays

Posted on: Wednesday,  Jun 18, 2014  12:00 AM ET by Barclays

Barclays rated Overweight Medtronic, Inc. (NYSE: MDT) on 06/18/2014, when the stock price was $63.77. Since
then, Medtronic, Inc. has gained 15.29% as of 08/27/2015's recent price of $73.52.
If you would have followed this Barclays's recommendation on MDT, you would have gained 15.28% of your investment in 435 days.

Medtronic, Inc. (Medtronic) is a global player in medical technology. The Company operates in seven segments that manufacture and sell device-based medical therapies: Cardiac Rhythm Disease Management, Spinal, CardioVascular, Neuromodulation, Diabetes, Surgical Technologies and Physio-Control. Through these seven segments, the Company develops, manufactures and markets its medical devices in more than 120 countries. Its primary products include those for cardiac rhythm disorders, cardiovascular disease, neurological disorders, spinal conditions and musculoskeletal trauma, urological and digestive disorders, diabetes, and ear, nose and throat conditions. The primary markets for products are the United States, Western Europe and Japan. In July 2008, it acquired Restore Medical, Inc. In November 2008, Medtronic acquired CryoCath Technologies Inc. In February 2009, it acquired Ablation Frontiers, Inc. and Ventor Technologies Ltd. In April 2009, Medtronic acquired CoreValve, Inc.

Barclays
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/18/2014 12:00 AM Buy
None
63.77 73.00
as of 10/17/2014
1 Week down  -3.30 %
1 Month down  -6.04 %
3 Months up  0.76 %
1 YTD down  -2.79 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy